Tysabri. Natalizumab is a treatment for people with relapsing forms of MSIt makes flares happen less often and keeps physical disabilities from getting worse quickly. Natalizumab sold under the brand name Tysabri among others is a medication used to treat multiple sclerosis and Crohns disease.
A Total ion chromatogram of the adalimumab sample. Tysabri is a laboratory-produced monoclonal antibody. The drug is believed to work by reducing the ability of inflammatory immune cells to attach to and pass through the cell layers.
Learn more and enroll today.
TYSABRI natalizumab is available only through the TOUCH Prescribing Program which stands for TYSABRI Outreach. It is designed to hamper movement of potentially damaging immune cells from the bloodstream. Unified Commitment to Health. Natalizumab is a treatment for people with relapsing forms of MSIt makes flares happen less often and keeps physical disabilities from getting worse quickly.